“Immune-Related Adverse Events After Combination Checkpoint Blockade: A Short Communication on Steroid-Sparing Practice” (2024) Translational Medicine & Therapeutics Journal, 3(2), pp. 110–119. doi:10.5281/zenodo.22649312.